TY - JOUR AU - Tang, Ling AU - Gao, Miao AU - Zuo, Xiuping PY - 2026 TI - Correlation between sleep disorders and immune function in elderly patients with lung cancer during chemotherapy and effect of non-pharmacological intervention JO - Chinese Journal of Multiple Organ Diseases in the Elderly SN - 1671-5403 SP - 326 EP - 331 VL - 25 IS - 5 AB - ObjectiveTo analyze the correlation between sleep disorders and immune function in elderly patients with lung cancer during chemotherapy and to evaluate the application effect of non-pharmacological intervention on sleep disorders.MethodsA questionnaire survey was conducted among 158 elderly lung cancer patients who received chemotherapy in Xijing Hospital, the First Affiliated Hospital of Air Force Military Medical University from January 2022 to December 2024. The questionnaire included sleep quality [Pittsburgh sleep quality index (PSQI)], physical status [Karnofsky performance status (KPS)], fatigue (cancer fatigue scale), anxiety [generalized anxiety disorder-7 (GAD-7)], depression [patient health questionnaire-9 (PHQ-9)], and pain [visual analogue scale (VAS)]. The effective recovery rate was 95.57% (151/158). According to PSQI score, the patients were divided into a sleep disorder group (PSQI≥7 points) and a good sleep group (PSQI< 7 points). The baseline data and immune function (T lymphocyte subsets CD4+, CD8+, CD4+/CD8+) before and after chemotherapy were compared between the two groups. Pearson correlation analysis was used to assess the correlation between PSQI scores and each indicator in elderly lung cancer patients undergoing chemotherapy. The sleep disorder group was divided into an observation group and a control group using random number table method. The control group received routine sleep health education, while the observation group was received additional psychological and exercise interventions. Changes in sleep quality (PSQI) and immune function (CD4+, CD8+, CD4+/CD8+) before intervention and after 2 weeks of intervention were compared. SPSS 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test, χ2 test or Mann whitney U test depending on data type.ResultsThe incidence rate of sleep disorders in elderly lung cancer patients undergoing chemotherapy was 35.76% (54/151). The scores of fatigue, GAD-7, PHQ-9, and VAS in the sleep disorder group were higher than those in the good sleep group (P< 0.05), while CD4+, CD8+, and CD4+/CD8+ after chemotherapy were lower than those in the good sleep group (P< 0.05). Pearson correlation analysis showed that PSQI scores in the elderly lung cancer patients undergoing chemotherapy was positively correlated with fatigue, GAD-7, PHQ-9, and VAS scores (r=0.543, 0.621, 0.595, 0.617; P< 0.05), and negatively correlated with post-chemotherapy CD4+, CD8+, and CD4+/CD8+ (r=-0.584, -0.489, -0.427; P< 0.05). The 54 patients in the sleep disorders were randomized into an observation group (n=27) and a control group (n=27), with 1 and 2 dropouts being excluded from the respective group. After 2 weeks of intervention, PSQI scores in both groups decreased compared with that before intervention (P< 0.05), and PSQI scores in observation group after intervention were lower than that in the control group (P< 0.05). There were no statistical differences in CD4+, CD8+, and CD4+/CD8+ between the two groups before and after intervention (all P> 0.05).ConclusionSleep disorders in elderly lung cancer patients during chemotherapy are related to immune function, pain, fatigue, anxiety, and depression. Non-pharmacological sleep interventions are beneficial for improving patients′ sleep quality, but short-term intervention has little effect on immune function. UR - https://doi.org/10.11915/j.issn.1671-5403.2026.05.068 DO - 10.11915/j.issn.1671-5403.2026.05.068